KR102648506B1 - Cosmetic composition containing mangrove root and guaajava leaf - Google Patents

Cosmetic composition containing mangrove root and guaajava leaf Download PDF

Info

Publication number
KR102648506B1
KR102648506B1 KR1020210151971A KR20210151971A KR102648506B1 KR 102648506 B1 KR102648506 B1 KR 102648506B1 KR 1020210151971 A KR1020210151971 A KR 1020210151971A KR 20210151971 A KR20210151971 A KR 20210151971A KR 102648506 B1 KR102648506 B1 KR 102648506B1
Authority
KR
South Korea
Prior art keywords
cosmetic composition
mangrove
extract
composition containing
guava
Prior art date
Application number
KR1020210151971A
Other languages
Korean (ko)
Other versions
KR20230066706A (en
Inventor
우재현
Original Assignee
(주)코이즈
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by (주)코이즈 filed Critical (주)코이즈
Priority to KR1020210151971A priority Critical patent/KR102648506B1/en
Publication of KR20230066706A publication Critical patent/KR20230066706A/en
Application granted granted Critical
Publication of KR102648506B1 publication Critical patent/KR102648506B1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59Mixtures
    • A61K2800/592Mixtures of compounds complementing their respective functions
    • A61K2800/5922At least two compounds being classified in the same subclass of A61K8/18

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

본 발명은 맹그로브 뿌리 및 구아바 잎 추출물을 함유하는 화장료 조성물에 관한 것으로서, 보다 상세하게는 맹그로브 뿌리 추출물과 구아바 잎으로부터 콜라겐 합성촉진, 항산화 및 항염 효과가 뛰어난 조성물을 제조하여 화장품 원료로 사용할 수 있도록 하는 맹그로브 뿌리 및 구아바 잎 추출물을 함유하는 화장료 조성물에 관한 것이다.
본 발명에 따르면 맹그로브 뿌리 추출물과 구아바 잎으로부터 콜라겐 합성촉진, 항산화 및 항염 효과가 뛰어난 조성물을 추출하여 사용할 수 있도록 하는 효과가 있다.
The present invention relates to a cosmetic composition containing mangrove root and guava leaf extract, and more specifically, to prepare a composition with excellent collagen synthesis promoting, antioxidant and anti-inflammatory effects from mangrove root extract and guava leaf, which can be used as a cosmetic raw material. It relates to a cosmetic composition containing mangrove root and guava leaf extract.
According to the present invention, a composition with excellent collagen synthesis promotion, antioxidant and anti-inflammatory effects can be extracted and used from mangrove root extract and guava leaves.

Description

맹그로브 뿌리 및 구아바 잎 추출물을 함유하는 화장료 조성물{COSMETIC COMPOSITION CONTAINING MANGROVE ROOT AND GUAAJAVA LEAF}Cosmetic composition containing mangrove root and guava leaf extract {COSMETIC COMPOSITION CONTAINING MANGROVE ROOT AND GUAAJAVA LEAF}

본 발명은 맹그로브 뿌리 및 구아바 잎 추출물을 함유하는 화장료 조성물에 관한 것으로서, 보다 상세하게는 맹그로브 뿌리 추출물과 구아바 잎으로부터 콜라겐 합성촉진, 항산화 및 항염 효과가 뛰어난 조성물을 제조하여 화장품 원료로 사용할 수 있도록 하는 맹그로브 뿌리 및 구아바 잎 추출물을 함유하는 화장료 조성물에 관한 것이다.The present invention relates to a cosmetic composition containing mangrove root and guava leaf extract, and more specifically, to prepare a composition with excellent collagen synthesis promoting, antioxidant and anti-inflammatory effects from mangrove root extract and guava leaf, which can be used as a cosmetic raw material. It relates to a cosmetic composition containing mangrove root and guava leaf extract.

자외선 등 내외적인 여러 가지 스트레스에 의해 일어나는 피부 현상은 피부두께의 변화와 함께 세포수 감소 및 피부 신진대사 저하, 생체결합수 손실을 비롯하여 콜라겐, 엘라스틴 등의 파괴로 주름지고 거칠은 피부표면의 형태로 나타나게 되는 피부노화를 억제하기 위해 콜라겐 합성 촉진, 항염증 효과 이외에 항산화 효과도 필수적으로 요구되는 데, 여기서 항산화 효과라 함은 화장품에 유연제로 사용되는 유지, 오일들이 공기 중 또는 물속에 녹아있는 용존산소 및 자외선으로부터 유발된 활성라디칼 등에 의해 산화되고 분해되는 것을 막아주는 것을 의미한다. 화장품에서 항산화제로 사용되는 대표적 물질로는 디부틸히드록시아니졸, 디부틸히드록시톨루엔을 비롯하여 아스코르빈산 및 그 유도체, 토코페롤 및 그 유도체 등이 가장 많이 이용되고 있다. 그러나 디부틸히드록시아니졸과 디부틸히드록시톨루엔는 항산화 효과는 우수하지만 피부 부작용을 유발하는 것으로 알려져 있으며, 아스코르빈산 및 그 유도체, 토코페롤은 그 자체의 안정성이 나빠서 직접 사용하기 어려우며, 이들의 안정성을 개선시킨 비타민 C 유도체, 비타민 E 유도체들은 항산화 효과가 거의 없는 문제점이 있다.Skin phenomena that occur due to various internal and external stresses such as ultraviolet rays are changes in skin thickness, decreased cell count and skin metabolism, loss of bio-bound water, and destruction of collagen and elastin, resulting in a wrinkled and rough skin surface. In order to suppress skin aging, in addition to promoting collagen synthesis and anti-inflammatory effects, an antioxidant effect is also essential. Here, the antioxidant effect refers to dissolved oxygen dissolved in the air or water of fats and oils used as softeners in cosmetics. It means preventing oxidation and decomposition by active radicals induced by ultraviolet rays. Representative substances used as antioxidants in cosmetics include dibutylhydroxyanisole, dibutylhydroxytoluene, ascorbic acid and its derivatives, and tocopherol and its derivatives. However, dibutylhydroxyanisole and dibutylhydroxytoluene have excellent antioxidant effects but are known to cause skin side effects, and ascorbic acid and its derivatives and tocopherol are difficult to use directly due to their poor stability. The improved vitamin C and vitamin E derivatives have the problem of having little antioxidant effect.

그리고 염증반응은 외부 자극에 의한 동통, 발열, 발작, 종창, 기능상실 등을 특징으로 하며, 조직학적으로는 소동맥, 모세혈관 및 소정맥의 투과성과 혈류증가를 동반한 확장, 혈장단백을 함유한 혈장의 삼출, 백혈구의 염증부위로의 이동 등을 포함한 복잡한 증상 등이 관찰되며 항염은 외부 자극으로부터 위와 같은 현상으로 나타나는 조직의 파괴를 막는 일련의 작용을 말한다. 최근의 연구자료에서 쿠마린은 식세포의 활성을 감소시키고 시트룰린 생성을 낮춤으로서 항염효과를 가져온다는 것을 알았다.The inflammatory response is characterized by pain, fever, seizures, swelling, and loss of function due to external stimuli. Histologically, it is characterized by expansion of arterioles, capillaries, and venules with increased permeability and blood flow, and plasma containing plasma proteins. Complex symptoms, including exudation and migration of white blood cells to the inflamed area, are observed, and anti-inflammatory refers to a series of actions that prevent the destruction of tissues caused by the above phenomenon from external stimuli. Recent research data has shown that coumarin has an anti-inflammatory effect by reducing the activity of phagocytes and lowering citrulline production.

맹그로브 뿌리 추출물mangrove root extract

염증 억제 및 자유 라디칼을 소거하는 항산화 효과가 뛰어나 이를 함유하는 화장료 조성물은 항노화를 목적으로 하는 화장료 및 탈모 방 지, 발모 촉진용으로서 이용될 수 있다.It has excellent antioxidant effects in suppressing inflammation and scavenging free radicals, and cosmetic compositions containing it can be used as cosmetics for anti-aging purposes, preventing hair loss, and promoting hair growth.

망그로브 줄기의 물 추출물은 항균활성을 보이며, 외과수술 후 회복에 효과기 있는 것으로 알려져 있다. 이러한 망그로브의 효능은 나무껍질에 다량 함유되어 있는 탄닌성붐의 활성에 기인하는 것이며, Rhizophora 속의 나무껍질에는 10-36% 정도의 탄닌을 포함하는 페놀성 화합물이 함유되어 있는 것으로 알려져 있다.Water extract of mangrove stems has antibacterial activity and is known to be effective in recovery after surgery. The effectiveness of mangroves is due to the activity of tannins contained in large quantities in the bark, and the bark of trees of the Rhizophora genus is known to contain phenolic compounds containing about 10-36% of tannin.

구아바( Psidium guajava L) 잎 추출물Guava (Psidium guajava L) leaf extract

구아바 잎에는 다량의 탄닌이 있으며, 설사억제, 알레르기 억제, 혈당저하, 노화방지 항암, 혈관 투과성의 억제 등의 작용이 있으며, 알레르기성, 비염, 알레르기성, 피부염, 화분증, 기관지 천식 등의 알레르기성 질환, 습진, 감기, 급성 또는 만성 작용, 소화성궤양, 이질, 소화불량성 설사, 피로회복, 고혈압피부, 미백 등에 효과가 있다고 알려져 있다.Guava leaves contain a large amount of tannin, and have anti-diarrheal, allergy-inhibiting, blood sugar-lowering, anti-aging, anti-cancer, and vascular permeability inhibition effects, as well as allergic properties such as allergies, rhinitis, allergic dermatitis, hay fever, and bronchial asthma. It is known to be effective in treating diseases, eczema, colds, acute or chronic effects, peptic ulcers, dysentery, dyspeptic diarrhea, fatigue recovery, hypertensive skin, and whitening.

타닌은 타닌산이라고 불리는데 분말, 엽편상 또는 해면덩어리 형태의 연노랑 색에서 밝은 갈색을 띠고 있는 무정형 물질이다. 식물에 분포되어 있으며, 타닌 용액은 산성을 띠며 떫은맛이 난다. 지혈작용과 수렴작용이 있어 편도선염, 인후염, 치질, 피부발진 등을 치료하는데도 사용되어 왔고, 설사와 장출혈을 멈추는데도 복용하며, 금속/알칼로이드/배당체 등이 가지고 있는 독성분과 결합하여 불용성 침전물을 만들기 때문에 해독제로 사용되었다.Tannin, also called tannic acid, is an amorphous substance that is light yellow to light brown in the form of powder, flakes, or spongy lumps. Distributed in plants, the tannin solution is acidic and has an astringent taste. It has hemostatic and astringent effects, so it has been used to treat tonsillitis, sore throat, hemorrhoids, and skin rashes. It is also taken to stop diarrhea and intestinal bleeding. It combines with toxic substances contained in metals, alkaloids, and glycosides to form insoluble precipitates. It was used as an antidote.

KRKR 10-2017-0068015 10-2017-0068015 AA

전술한 문제점을 해결하기 위한 본 발명은 맹그로브 뿌리 추출물과 구아바 잎으로부터 콜라겐 합성촉진, 항산화 및 항염 효과가 뛰어난 조성물을 추출하여 사용할 수 있도록 하는 맹그로브 뿌리 및 구아바 잎 추출물을 함유하는 화장료 조성물을 제공하는 것을 목적으로 한다.The present invention to solve the above-mentioned problems is to provide a cosmetic composition containing mangrove root and guava leaf extract, which allows extracting and using a composition with excellent collagen synthesis promoting, antioxidant and anti-inflammatory effects from the mangrove root extract and guava leaf. The purpose.

전술한 문제점을 해결하기 위해 안출된 본 발명은 맹그로브 뿌리 및 구아바 잎 추출물을 함유하는 항노화 화장료 조성물로서, 맹그로브 뿌리와 구아바 잎을 함유하는 혼합 추출물 0.01 내지 10 중량%와; 산소수 0.1 내지 10 중량%와; 화장료 80 내지 99.89 중량%;로 이루어진다.The present invention, devised to solve the above-mentioned problems, is an anti-aging cosmetic composition containing mangrove root and guava leaf extracts, comprising: 0.01 to 10% by weight of a mixed extract containing mangrove root and guava leaf; 0.1 to 10% by weight of oxygen water; It consists of 80 to 99.89% by weight of cosmetics.

상기 혼합 추출물은 물, 에탄올, 글리세린, 부틸렌글리콜 및 프로필렌글리콜으로 구성된 그룹으로부터 선택된 하나 이상의 용매 또는 산소수와의 혼합 용매 중 어느 하나 이상을 용매로 사용하여 추출되는 것을 특징으로 한다.The mixed extract is characterized in that it is extracted using at least one solvent selected from the group consisting of water, ethanol, glycerin, butylene glycol, and propylene glycol, or a mixed solvent with oxygenated water as a solvent.

상기 산소수는 20 내지 200 ppm의 산소를 함유하고 있는 것을 특징으로 한다.The oxygen water is characterized in that it contains 20 to 200 ppm of oxygen.

상기 혼합 추출물은 상기 용매를 혼합한 후 50 내지 95 ℃의 온도에서 4 내지 20시간 동안 가열하여 추출하거나, 5 내지 37 ℃의 온도에서 1 내지 15일간 침적시켜 유효성분을 추출하는 것을 특징으로 한다.The mixed extract is characterized in that the active ingredients are extracted by mixing the solvents and then heating at a temperature of 50 to 95 ° C. for 4 to 20 hours, or by soaking the extract for 1 to 15 days at a temperature of 5 to 37 ° C.

상기 화장료 조성물은 용액, 현탁액, 유탁액, 페이스트, 겔, 크림, 로션, 파우더, 비누, 계면활성제-함유 클린징, 오일, 분말 파운데이션, 유탁액 파운데이션, 왁스 파운데이션 및 스프레이로 구성된 군으로부터 선택되는 포뮬레이션을 갖는 것을 특징으로 한다.The cosmetic composition is a formulation selected from the group consisting of solutions, suspensions, emulsions, pastes, gels, creams, lotions, powders, soaps, surfactant-containing cleansing agents, oils, powder foundations, emulsion foundations, wax foundations and sprays. It is characterized by having a.

본 발명에 따르면 맹그로브 뿌리 추출물과 구아바 잎으로부터 항산화 및 항염 효과가 뛰어난 조성물을 추출하여 사용할 수 있도록 하는 효과가 있다.According to the present invention, a composition with excellent antioxidant and anti-inflammatory effects can be extracted and used from mangrove root extract and guava leaves.

이하에서 도면을 참조하여 본 발명의 실시예에 따른 "맹그로브 뿌리 및 구아바 잎 추출물을 함유하는 화장료 조성물"(이하, '화장료 조성물'이라 함)을 설명한다.Hereinafter, a "cosmetic composition containing mangrove root and guava leaf extract" (hereinafter referred to as 'cosmetic composition') according to an embodiment of the present invention will be described with reference to the drawings.

상기 문제점을 보다 효과적으로 해결하기 위하여 연구한 결과 맹그로브 뿌리 추출물과 구아바 잎 추출물을 함유하는 화장료 조성물은 항산화 및 항염 등에서 피부에 안전하면서도 우수한 효과를 나타내어 피부 안전성과 효능성이 탁월한 화장료 조성물임을 발견하게 되었다.As a result of research to more effectively solve the above problems, it was discovered that a cosmetic composition containing mangrove root extract and guava leaf extract is safe and has excellent effects on the skin in terms of antioxidant and anti-inflammatory properties, making it a cosmetic composition with excellent skin safety and efficacy.

본 발명을 좀 더 상세히 설명하면 다음과 같다. 맹그로브 뿌리와 구아바 잎을 완전건조한 후 건조중량에 대하여 추출 용매로서 물, 에탄올, 글리세린, 부틸렌글리콜 및 프로필렌글리콜으로 구성된 그룹으로부터 선택된 하나 이상의 용매 또는 산소수와의 혼합 용매를 1-20배 부피량을 가한다. The present invention will be described in more detail as follows. After completely drying the mangrove roots and guava leaves, 1-20 times the volume of one or more solvents selected from the group consisting of water, ethanol, glycerin, butylene glycol, and propylene glycol or a mixed solvent with oxygen water as an extraction solvent relative to the dry weight. apply.

추출 방법으로는 냉각 콘덴서가 장치되어 용매가 증발되는 것을 방지한 상태에서 50-95 ℃, 4-20시간 가열하여 추출하거나 5-37 ℃에서 1-15일간 침적시켜 유효성분을 추출하는 방법을 사용할 수 있다. 이렇게 맹그로브 뿌리와 구아바 잎을 혼합하여 추출한 혼합 추출물을 냉각 콘덴서가 달린 증류장치를 이용하여 증발되어 나오는 용매를 회수하면서 완전히 감압 농축한 후 그 건조중량으로서 0.01 내지 10중량%, 바람직하게는 0.01 내지 5중량%의 양으로 화장료에 첨가하는 것이다. 다시 말하면 유연화장수(스킨), 영양화장수(로션), 영양크림, 마사지 크림, 엣센스, 팩, 유화형 화운데이션 등에 첨가하는 것이다.Extraction methods include heating at 50-95 ℃ for 4-20 hours with a cooling condenser to prevent evaporation of the solvent, or soaking at 5-37 ℃ for 1-15 days to extract the active ingredient. You can. The mixed extract obtained by mixing mangrove roots and guava leaves in this way is completely concentrated under reduced pressure while recovering the evaporated solvent using a distillation device equipped with a cooling condenser, and then 0.01 to 10% by weight of the dry weight, preferably 0.01 to 5%. It is added to cosmetics in an amount of % by weight. In other words, it is added to softening lotion (skin), nourishing lotion (lotion), nourishing cream, massage cream, essence, pack, emulsified foundation, etc.

화장료 조성물은 혼합 추출물과 산소수, 화장료로 이루어지며, 산소수는 0.1 내지 10 중량%가 포함되며, 화장료는 80 내지 99.89 중량%가 포함된다. 특히 산소수는 산소 함유량이 20 내지 200 PPM인 것이 바람직하다.The cosmetic composition consists of a mixed extract, oxygen water, and cosmetics, and contains 0.1 to 10% by weight of oxygen water and 80 to 99.89% by weight of cosmetics. In particular, the oxygen water preferably has an oxygen content of 20 to 200 PPM.

아래의 실시예 및 실험 예는 본 발명의 내용을 설명하나, 본 발명의 내용이 여기에 한정되지는 않는다.The following examples and experimental examples illustrate the content of the present invention, but the content of the present invention is not limited thereto.

실시예Example

맹그로브 뿌리와 구아바 잎 혼합추출물의 항산화, 항염 효과를 확인하기 위하여 혼합 추출물을 하기의 용매를 사용하여 제조하였다. 실시예 1~18에서는 추출액을 건조시키지 않은 상태로 제조하였고, 실시예 19~22에서는 혼합 추출물을 건조시켜 분말상으로 제조하였다. 실시예 1~9 및 19~22에서는 추출기에서 혼합물을 침적시키는 방법을 적용하였고, 실시예 9~18에서는 추출기에서 혼합물을 가열시키는 방법에 의하여 혼합 추출물을 제조하였다.To confirm the antioxidant and anti-inflammatory effects of the mixed extract of mangrove roots and guava leaves, the mixed extract was prepared using the following solvent. In Examples 1 to 18, the extract was prepared without drying, and in Examples 19 to 22, the mixed extract was dried and prepared in powder form. In Examples 1 to 9 and 19 to 22, a method of depositing the mixture in an extractor was applied, and in Examples 9 to 18, a mixed extract was prepared by heating the mixture in an extractor.

본 발명의 실시예에서는 맹그로브 뿌리와 구아바 잎을 각각 500g 씩, 총 1 kg을 사용하였다.In the examples of the present invention, 500 g each of mangrove roots and guava leaves were used, for a total of 1 kg.

실시예 1~9Examples 1 to 9

실시예 1~9에서는 맹그로브 뿌리와 구아바 잎의 건조혼합물 1 kg을 정제수로 세척한 다음, 하기 표 1의 용매 6 kg에 넣고 추출기로 상온에서 5일간 침적시켜 추출한 후, 400 메쉬 여과포로 여과하고 0.45 ㎛의 필터로 여과하여 액상 혼합추출물을 얻었다.In Examples 1 to 9, 1 kg of the dry mixture of mangrove roots and guava leaves was washed with purified water, then added to 6 kg of the solvent shown in Table 1 below, extracted by soaking at room temperature for 5 days with an extractor, filtered through a 400 mesh filter cloth, and 0.45 A liquid mixed extract was obtained by filtration through a ㎛ filter.

실시예 10~18Examples 10-18

맹그로브 뿌리와 구아바 잎의 건조혼합물 1kg을 하기 표 2의 용매 6kg에 넣고 냉각 콘덴서가 장치되어 용매가 증발되는 것을 방지한 상태에서 80 ℃의 온도 하에서 3시간 동안 가열한 뒤, 400 메쉬 여과포로 여과한 후, 0.45 ㎛의 필터로 여과하여 액상 혼합추출물을 얻었다.1kg of the dry mixture of mangrove roots and guava leaves was added to 6kg of the solvent shown in Table 2 below, heated at a temperature of 80°C for 3 hours with a cooling condenser to prevent the solvent from evaporating, and then filtered through a 400 mesh filter cloth. Afterwards, it was filtered through a 0.45 ㎛ filter to obtain a liquid mixed extract.

실시예 19~22Examples 19-22

정제수로 세척한 맹그로브 뿌리와 구아바 잎의 건조혼합물 1kg을 하기 표 3의 용매 6kg에 넣고 추출기로 상온에서 6일간 침적시켜 추출한 후, 400 메쉬 여과포로 여과한 뒤, 0.45 ㎛의 필터로 여과하였다. 여과되어 나온 용액을 냉각 콘덴서가 달린 증류장치를 이용하여 감압 건조시켜 분말상태의 혼합추출물을 얻었다.1kg of the dried mixture of mangrove roots and guava leaves washed with purified water was added to 6kg of the solvent shown in Table 3 below, extracted by immersing it in an extractor at room temperature for 6 days, filtered through a 400 mesh filter cloth, and then filtered through a 0.45 ㎛ filter. The filtered solution was dried under reduced pressure using a distillation device equipped with a cooling condenser to obtain a mixed extract in powder form.

항산화 효과 실험Antioxidant effect experiment

유리병에 농도별 맹그로브 뿌리와 구아바 잎 혼합 추출물을 20 ㎕ 넣고, 리놀레산 용액(0.5 ㎖의 리놀레산에 tween 60(40% W/V) 0.25 ㎖ 먼저 섞은 후, 산소수 50 ㎖ 가해 약 5분 동안 유화시키고, 1 N KOH 25 ㎕를 사용하여 중화시킨 다음, 0.05 M potassium phosphate buffer(pH 7.0) 110 ㎖를 넣어 재분산시켰다. 최종 부피는 160 ㎖ 정도이다)을 10 ㎖ 넣은 후, 진탕배양기(shaking incubator)에서 180 rpm, 37 ℃에서 1시간 반응시켰다. 다음에 0,0375 M FeSO4·7H2O를 20 ㎕ 첨가하여 과산화화(peroxidation)시켰다. 첨가 후 진탕배양기에서 180 rpm, 37 ℃에서 2시간 반응시켰다. 리놀레산 용액 400 ㎕를 E-tube에 넣고 4 ℃에서 10 분간 냉침 후, TBA 시약(TBA 43 ㎎을 DW 10 ㎖에 용해하고, 거기에 6 M 인산 용액 2 ㎖를 가하였다. 사용직전에 혼합하였다.)을 200 ㎕ 첨가하여 혼합하고, 15 분 동안 끓는 물에서 발색시켰다. 얼음물에 냉각시키고, n-BuOH 560 ㎕를 넣어 혼합하였다. 20분 동안 3000 rpm에서 원심 분리하고, BuOH(상등액) 부분을 UV-Spectrum 535 ㎚에서 흡광도를 측정하였다. 측정 결과를 표 4에 나타내었다.Put 20 ㎕ of mixed extract of mangrove roots and guava leaves of each concentration in a glass bottle, mix 0.25 ㎖ of tween 60 (40% W/V) with 0.5 ㎖ of linoleic acid first, and then add 50 ㎖ of oxygenated water and emulsify for about 5 minutes. and neutralized using 25 ㎕ of 1 N KOH, then redispersed by adding 110 ㎖ of 0.05 M potassium phosphate buffer (pH 7.0). After adding 10 ㎖ (the final volume is about 160 ㎖), it was placed in a shaking incubator. ) was reacted at 180 rpm and 37°C for 1 hour. Next, 20 ㎕ of 0,0375 M FeSO 4 ·7H 2 O was added for peroxidation. After addition, it was reacted in a shaking incubator at 180 rpm and 37°C for 2 hours. 400 ㎕ of linoleic acid solution was placed in an E-tube and cold soaked at 4°C for 10 minutes. TBA reagent (43 mg of TBA) was dissolved in 10 ml of DW, and 2 ml of 6 M phosphoric acid solution was added thereto. It was mixed immediately before use. ) was added and mixed, and color was developed in boiling water for 15 minutes. It was cooled in ice water, and 560 ㎕ of n-BuOH was added and mixed. Centrifugation was performed at 3000 rpm for 20 minutes, and the absorbance of the BuOH (supernatant) portion was measured at UV-Spectrum 535 nm. The measurement results are shown in Table 4.

이중 상기 실시예 16에서 제조된 혼합추출물에 대하여 각각의 농도에 따른 항산화 효과를 별도로 측정하여 표 5에 나타내었다.Among them, the antioxidant effect of the mixed extract prepared in Example 16 was measured separately at each concentration and is shown in Table 5.

항염 효과 실험Anti-inflammatory effect experiment

1 mM 리놀레산 1 ㎖에 맹그로브 뿌리와 구아바 잎 혼합 추출물 0.05 ㎖, 0.1 M의 인산나트륨 버퍼에 용해시킨 11,060 units/㎖ lipoxygenase 0.95 ㎖를 넣은 후 잘 혼합하고, 25 ℃의 수욕조에서 15분간 반응시켰다. 20 %(w/v) 트리클로로아세트산 0.5 ㎖를 넣어 반응을 종결시키고, 0.6 %(w/v) TBA를 1 ㎖ 넣은 후 끓는 물에서 15 분간 발색시켰다. 그 후 얼음물에 2분간 냉침시키고, n-BuOH 2 ㎖를 넣고 진탕혼합한 후, 3,500 rpm, 5분간 원심분리하였다.To 1 ml of 1 mM linoleic acid, 0.05 ml of mixed extract of mangrove roots and guava leaves, and 0.95 ml of 11,060 units/ml lipoxygenase dissolved in 0.1 M sodium phosphate buffer were added, mixed well, and reacted in a water bath at 25°C for 15 minutes. The reaction was terminated by adding 0.5 ml of 20% (w/v) trichloroacetic acid, 1 ml of 0.6% (w/v) TBA was added, and color was developed in boiling water for 15 minutes. Afterwards, it was immersed in ice water for 2 minutes, 2 ml of n-BuOH was added, mixed by shaking, and then centrifuged at 3,500 rpm for 5 minutes.

상층(n-BuOH층)을 취하여 UV-Visible spectrum 535 nm 에서 흡광도를 측정하여 항염 효과(%) 를 평가하였다. 대조포준은 혼합 추출물 대신 용매를 사용하였다. 블랭크는 lipoxygenase 대신 0.1 M 인산나트륨 버퍼를 사용하였다. 측정 결과를 표 6에 나타내었다.The upper layer (n-BuOH layer) was taken and the absorbance was measured at 535 nm in the UV-Visible spectrum to evaluate the anti-inflammatory effect (%). For the control standard, a solvent was used instead of the mixed extract. For the blank, 0.1 M sodium phosphate buffer was used instead of lipoxygenase. The measurement results are shown in Table 6.

상기 실시예 16에서 제조된 혼합추출물에 대하여 각각의 농도에 따른 항염 효과를 별도로 측정하여 표 7에 나타내었다.The anti-inflammatory effect of the mixed extract prepared in Example 16 was measured separately at each concentration and is shown in Table 7.

피부자극성시험(폐쇄첩포실험)Skin irritation test (closed patch test)

본 맹그로브 뿌리와 구아바 잎 혼합추출물(실시예 16) 10%, 30% 수용액 및 소디움라우릴설페이트 0.08% 수용액을 건강한 성인 남, 여 20명을 대상으로 등부위에 각 시료의 일정량(0.2g)을 24시간 첩포한 후 핀챔버를 제거하고 4시간 경과한 다음 육안으로 피부상태 변화를 판독하여 그 결과를 표 8에 나타내었다.This mangrove root and guava leaf mixed extract (Example 16) 10%, 30% aqueous solution and 0.08% sodium lauryl sulfate aqueous solution were administered to 20 healthy adult men and women, and a certain amount (0.2 g) of each sample was applied to the back area for 24 hours. After applying the patch for a while, the pin chamber was removed, and after 4 hours, the change in skin condition was read with the naked eye, and the results are shown in Table 8.

** 피부 자극성 시험결과 **** Skin irritation test results **

※ 판정기준 - ; 홍반이나 특이한 현상없음※ Criteria - ; No erythema or unusual symptoms

+- ; 주위보다 약간 붉어짐 +- ; Slightly redder than the surrounding area

+ ; 주위보다 현저히 붉어짐 + ; Significantly redder than surroundings

++ ; 주위보다 심하게 붉어지고 부풀어오름 ++ ; Severe redness and swelling compared to the surrounding area

Figure 112021128209795-pat00008
Figure 112021128209795-pat00008

분말상 시료의 피부1차 자극성시험(폐쇄첩포실험)Primary skin irritation test of powder samples (closed patch test)

분말상태의 추출물 0.5g을 100g의 정제수에 녹여 실험 5와 동일한 방법으로 시행하였고 결과를 표 9에 나타내었다.0.5 g of the powdered extract was dissolved in 100 g of purified water and conducted in the same manner as Experiment 5, and the results are shown in Table 9.

상기 실시예에서 제조 원료를 사용하여 아래 처방예와 같은 방법으로 제조하였다.It was manufactured in the same manner as the prescription example below using the raw materials used in the above examples.

처방예 1Prescription example 1

맹그로브 뿌리와 구아바 잎 혼합 추출물을 함유한 화장료중 화장수(스킨로션)의 처방예는 다음과 같다. 여기에서 맹그로브 뿌리와 구아바 잎 혼합 추출물은 실시예 16의 것이다.Prescription examples of lotion (skin lotion) among cosmetics containing mixed extracts of mangrove roots and guava leaves are as follows. Here, the mixed extract of mangrove roots and guava leaves is that of Example 16.

〈제조방법〉〈Manufacturing method〉

제형예 1 : 11번에 2,3,4,8번을 순서대로 투입하여 교반하여 용해시킨 후 5번을 60℃정도 가열하여 용해시킨 후, 10번을 투입 교반하여 11번에 투입한다. 마지막으로 1,6,7,9번을 투입하여 충분히 교반한 뒤 숙성시킨다.Formulation Example 1: Add No. 2, 3, 4, and 8 in order to No. 11 and stir to dissolve. After dissolving No. 5 by heating to about 60°C, add No. 10, stir, and add to No. 11. Lastly, add Nos. 1, 6, 7, and 9, stir sufficiently, and then age.

비교제형예 1 : 11번에 2,3,4,8번을 순서대로 투입하여 교반하여 용해시킨 후 5번을 60℃정도 가열하여 용해시킨 후, 10번을 투입 교반하여 11번에 투입한다. 마지막으로 6,7,9번을 투입하여 충분히 교반한 뒤 숙성시킨다.Comparative Formulation Example 1: Add No. 2, 3, 4, and 8 in order to No. 11 and stir to dissolve. After dissolving No. 5 by heating to about 60°C, add No. 10, stir, and add to No. 11. Lastly, add Nos. 6, 7, and 9, stir thoroughly, and then age.

처방예 2Prescription example 2

맹그로브 뿌리와 구아바 잎 혼합 추출물을 함유한 화장료중 영양로숀의 처방예는 다음과 같다. 여기에서 맹그로브 뿌리와 구아바 잎 혼합 추출물은 실시예 16의 것이다.Examples of nutritional lotion formulations among cosmetics containing mixed extracts of mangrove roots and guava leaves are as follows. Here, the mixed extract of mangrove roots and guava leaves is that of Example 16.

〈제조방법〉〈Manufacturing method〉

제형예 2 : 원료물질 2,3,4,5 및 6을 일정한 온도에서 균질화하여 비이온계 양친매성 지질이라 칭한다. 상기 비이온계 양친매성 지질과 원료물질 1,7,8 및 14를 혼합하고 일정한 온도에서 균질화한 후, 원료물질 9를 일정한 온도에서 서서히 첨가하여 균질화한다. 그 후 10,11,12,13를 투입하여 분산시켜 안정화하고 숙성시킨다.Formulation Example 2: Raw materials 2, 3, 4, 5, and 6 are homogenized at a constant temperature and are referred to as nonionic amphiphilic lipids. The nonionic amphiphilic lipid and raw materials 1, 7, 8, and 14 are mixed and homogenized at a constant temperature, and then the raw material 9 is slowly added at a constant temperature and homogenized. Afterwards, 10, 11, 12, and 13 are added and dispersed to stabilize and mature.

비교제형예 2 : 원료물질 2,3,4,5 및 6을 일정한 온도에서 균질화하여 비이온계 양친매성 지질이라 칭한다. 상기 비이온계 양친매성 지질과 원료물질 7,8 및 14를 혼합하고 일정한 온도에서 균질화한 후, 원료물질 9를 일정한 온도에서 서서히 첨가하여 균질화한다. 그 후 10,11,12,13를 투입하여 분산시켜 안정화하고 숙성시킨다.Comparative Formulation Example 2: Raw materials 2, 3, 4, 5, and 6 were homogenized at a constant temperature and were referred to as nonionic amphiphilic lipids. The nonionic amphiphilic lipid and raw materials 7, 8, and 14 are mixed and homogenized at a constant temperature, and then the raw material 9 is slowly added at a constant temperature and homogenized. Afterwards, 10, 11, 12, and 13 are added and dispersed to stabilize and mature.

처방예 3Prescription example 3

맹그로브 뿌리와 구아바 잎 혼합 추출물을 함유한 화장료중 영양크림의 처방예는 다음과 같다. 여기에서 맹그로브 뿌리 구아바 잎 혼합 추출물은 실시예 16의 것이다.An example of a nutritional cream formulation among cosmetics containing mixed extracts of mangrove roots and guava leaves is as follows. Here, the mangrove root and guava leaf mixed extract is from Example 16.

〈제조방법〉〈Manufacturing method〉

제형예 3 : 원료물질 2,3,4,5 및 6을 일정한 온도에서 균질화하여 비이온계 양친매성 지질이라 칭한다. 상기 비이온계 양친매성 지질과 원료물질 1,7,8 및 14을 혼합하고 일정한 온도에서 균질화한다. 그리고 원료물질 9를 일정한 온도에서 서서히 첨가하여 균질화한 후 10,11,12,13를 투입하여 분산시켜 안정화하고 숙성시킨다.Formulation Example 3: Raw materials 2, 3, 4, 5, and 6 are homogenized at a constant temperature and are referred to as nonionic amphiphilic lipids. The nonionic amphiphilic lipid and raw materials 1, 7, 8, and 14 are mixed and homogenized at a constant temperature. Then, raw material 9 is slowly added at a constant temperature to homogenize it, and then 10, 11, 12, and 13 are added and dispersed to stabilize and mature.

비교제형예 3 : 원료물질 2,3,4,5 및 6을 일정한 온도에서 균질화하여 비이온계 양친매성 지질이라 칭한다. 상기 비이온계 양친매성 지질과 원료물질 7,8 및 14을 혼합하고 일정한 온도에서 균질화한다. 그리고 원료물질 9를 일정한 온도에서 서서히 첨가하여 균질화한 후 10,11,12,13를 투입하여 분산시켜 안정화하고 숙성시킨다.Comparative Formulation Example 3: Raw materials 2, 3, 4, 5, and 6 were homogenized at a constant temperature and were referred to as nonionic amphiphilic lipids. The nonionic amphiphilic lipid and raw materials 7, 8, and 14 are mixed and homogenized at a constant temperature. Then, raw material 9 is slowly added at a constant temperature to homogenize it, and then 10, 11, 12, and 13 are added and dispersed to stabilize and mature.

시험예 1Test example 1

상기 처방예 1~3에서의 제형예 1~3과 비교제형예 1~3에 대하여 피부 자극 효과에 관한 실험을 다음과 같이 측정 하였다. 제형 및 소디움라우릴설페이트 0.08% 수용액을 건강한 성인 남,여 20명을 대상으로 등부위에 각 시료의 일정량(0.2g)을 24시간 첩포한 후 핀챔버를 제거하고 4시간 경과한 다음 육안으로 피부상태 변화를 판독하여 그 결과를 표10에 나타내었다.An experiment on the skin irritation effect of Formulation Examples 1 to 3 and Comparative Formulation Examples 1 to 3 in Prescription Examples 1 to 3 was measured as follows. Formulation and sodium lauryl sulfate 0.08% aqueous solution were applied to the back of 20 healthy adult men and women. A certain amount (0.2 g) of each sample was applied for 24 hours. The pin chamber was removed, and after 4 hours, the skin condition was examined with the naked eye. The changes were read and the results are shown in Table 10.

** 피부 자극성 시험결과 **** Skin irritation test results **

※ 판정기준 - ; 홍반이나 특이한 현상없음※ Criteria - ; No erythema or unusual symptoms

+- ; 주위보다 약간 붉어짐 +- ; Slightly redder than the surrounding area

+ ; 주위보다 현저히 붉어짐 + ; Significantly redder than surroundings

++ ; 주위보다 심하게 붉어지고 부풀어오름 ++ ; Severe redness and swelling compared to the surrounding area

Figure 112021128209795-pat00014
Figure 112021128209795-pat00014

이상 첨부된 도면을 참조하여 본 발명의 바람직한 실시예를 설명하였지만, 상술한 본 발명의 기술적 구성은 본 발명이 속하는 기술 분야의 당업자가 본 발명의 그 기술적 사상이나 필수적 특징을 변경하지 않고서 다른 구체적인 형태로 실시될 수 있다는 것을 이해할 수 있을 것이다. 그러므로 이상에서 기술한 실시예들은 모든 면에서 예시적인 것이며 한정적인 것이 아닌 것으로서 이해되어야 하고, 본 발명의 범위는 상기 상세한 설명보다는 후술하는 특허청구범위에 의하여 나타내어지며, 특허청구범위의 의미 및 범위 그리고 그 등가 개념으로부터 도출되는 모든 변경 또는 변형된 형태가 본 발명의 범위에 포함되는 것으로 해석되어야 한다.Although the preferred embodiments of the present invention have been described with reference to the accompanying drawings, the technical configuration of the present invention described above can be changed to other specific forms by those skilled in the art without changing the technical idea or essential features of the present invention. You will be able to understand that this can be implemented. Therefore, the embodiments described above should be understood in all respects as illustrative and not restrictive, and the scope of the present invention is indicated by the claims described later rather than the detailed description above, and the meaning and scope of the claims and All changes or modified forms derived from the equivalent concept should be construed as falling within the scope of the present invention.

Claims (5)

맹그로브 뿌리 및 구아바 잎 추출물을 함유하는 화장료 조성물로서,
맹그로브 뿌리와 구아바 잎을 함유하는 혼합 추출물 0.01 내지 10 중량%와;
산소수 0.1 내지 10 중량%와;
화장료 80 내지 99.89 중량%;로 이루어지는, 맹그로브 뿌리 및 구아바 잎 추출물을 함유하는 화장료 조성물.
A cosmetic composition containing mangrove root and guava leaf extract,
0.01 to 10% by weight of a mixed extract containing mangrove roots and guava leaves;
0.1 to 10% by weight of oxygen water;
A cosmetic composition containing mangrove root and guava leaf extract, consisting of 80 to 99.89% by weight of cosmetic.
제1항에 있어서,
상기 혼합 추출물은 물, 에탄올, 글리세린, 부틸렌글리콜 및 프로필렌글리콜으로 구성된 그룹으로부터 선택된 하나 이상의 용매 또는 상기 하나 이상의 용매와 산소수의 혼합 용매 중 어느 하나를 용매로 사용하여 추출되는 것을 특징으로 하는, 맹그로브 뿌리 및 구아바 잎 추출물을 함유하는 화장료 조성물.
According to paragraph 1,
The mixed extract is characterized in that it is extracted using either one or more solvents selected from the group consisting of water, ethanol, glycerin, butylene glycol, and propylene glycol, or a mixed solvent of the one or more solvents and oxygen water as a solvent, A cosmetic composition containing extracts of mangrove roots and guava leaves.
제1항에 있어서,
상기 산소수는 20 내지 200 ppm의 산소를 함유하고 있는 것을 특징으로 하는, 맹그로브 뿌리 및 구아바 잎 추출물을 함유하는 화장료 조성물.
According to paragraph 1,
A cosmetic composition containing mangrove root and guava leaf extract, wherein the oxygen water contains 20 to 200 ppm of oxygen.
제2항에 있어서,
상기 혼합 추출물은 상기 용매를 혼합한 후 50 내지 95 ℃의 온도에서 4 내지 20시간 동안 가열하여 추출하거나, 5 내지 37 ℃의 온도에서 1 내지 15일간 침적시켜 유효성분을 추출하는 것을 특징으로 하는, 맹그로브 뿌리 및 구아바 잎 추출물을 함유하는 화장료 조성물.
According to paragraph 2,
The mixed extract is characterized in that the active ingredient is extracted by mixing the solvents and then heating at a temperature of 50 to 95 ° C. for 4 to 20 hours, or soaking the extract for 1 to 15 days at a temperature of 5 to 37 ° C. A cosmetic composition containing extracts of mangrove roots and guava leaves.
제1항에 있어서,
상기 화장료 조성물은 용액, 현탁액, 유탁액, 페이스트, 겔, 크림, 로션, 파우더, 비누, 계면활성제-함유 클린징, 오일, 분말 파운데이션, 유탁액 파운데이션, 왁스 파운데이션 및 스프레이로 구성된 군으로부터 선택되는 포뮬레이션을 갖는 것을 특징으로 하는, 맹그로브 뿌리 및 구아바 잎 추출물을 함유하는 화장료 조성물.
According to paragraph 1,
The cosmetic composition is a formulation selected from the group consisting of solutions, suspensions, emulsions, pastes, gels, creams, lotions, powders, soaps, surfactant-containing cleansing agents, oils, powder foundations, emulsion foundations, wax foundations and sprays. A cosmetic composition containing mangrove root and guava leaf extract, characterized in that it has.
KR1020210151971A 2021-11-08 2021-11-08 Cosmetic composition containing mangrove root and guaajava leaf KR102648506B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020210151971A KR102648506B1 (en) 2021-11-08 2021-11-08 Cosmetic composition containing mangrove root and guaajava leaf

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020210151971A KR102648506B1 (en) 2021-11-08 2021-11-08 Cosmetic composition containing mangrove root and guaajava leaf

Publications (2)

Publication Number Publication Date
KR20230066706A KR20230066706A (en) 2023-05-16
KR102648506B1 true KR102648506B1 (en) 2024-03-18

Family

ID=86546232

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020210151971A KR102648506B1 (en) 2021-11-08 2021-11-08 Cosmetic composition containing mangrove root and guaajava leaf

Country Status (1)

Country Link
KR (1) KR102648506B1 (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101450089A (en) 2008-12-17 2009-06-10 华宝食用香精香料(上海)有限公司 Mangrove extract liquid and preparation method thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3193441B2 (en) * 1992-03-09 2001-07-30 御木本製薬株式会社 Whitening cosmetics
KR20090091505A (en) * 2008-02-25 2009-08-28 (주)아모레퍼시픽 Composition for skin whitening containing oxygen dissolving water
KR101334485B1 (en) * 2011-11-07 2013-11-29 주식회사 바이오에프디엔씨 A Skin External Composition Containing Callus Extract Drived from Rhizophora Mangle
KR101865181B1 (en) * 2011-11-24 2018-06-08 (주)아모레퍼시픽 Cosmetic composition for skin cell activation
KR20170068015A (en) 2015-12-09 2017-06-19 (주)코이즈 Cosmetic composition containing pinus radiata and psidium guaajava leaf having anti-oxidant and anti-inflammatory activity

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101450089A (en) 2008-12-17 2009-06-10 华宝食用香精香料(上海)有限公司 Mangrove extract liquid and preparation method thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Indian J. Geo Marine Sci. 41(3):259-264

Also Published As

Publication number Publication date
KR20230066706A (en) 2023-05-16

Similar Documents

Publication Publication Date Title
CN106473987B (en) The anti-ageing composition of whitening and cosmetics
CN111481481B (en) Spun gold royal chrysanthemum nanotechnology skin care product and preparation method and application thereof
AU2006246923A1 (en) System and method for promoting hair growth and improving hair and scalp health
KR20160125784A (en) Shiunko fermented oil and producing method thereof
KR101627051B1 (en) Natural liposome comprising vitamin C, process for the preparation thereof, and cosmetic composition comprising the same
KR101736714B1 (en) Cosmetic composition for improvement of skin function comprising natural extract
KR101142541B1 (en) Anti-wrinkle cosmetic composition containing oriental herb extract treated by enzyme and its extraction method
CN101664370B (en) Eriocaulon henryanum Ruhl P.E. and application thereof in cosmetics
JP5196416B2 (en) Cosmetic composition containing Limnocitrus litoritalis extract
KR102648506B1 (en) Cosmetic composition containing mangrove root and guaajava leaf
TR202008828A2 (en) METHOD OF OBTAINING HIPPOPHAE RHAMNOIDES EXTRACT ENCAPSULATED WITH LIPOSOMAL TECHNOLOGY FOR USE IN COSMETIC FORMULAS
CN115429725B (en) Cosmetic composition for antioxidation, anti-inflammatory and skin tranquilization
KR102025859B1 (en) Cosmetic or phamaceutical composition comprising herb extract and method for preparing the same
KR20110037462A (en) Cosmetic composition containing neem extract for alleviating skin inflammation
KR20190137328A (en) Skin external application composition for anti-aging containing Rhodotypos scandens extract
KR20190137329A (en) Skin external application composition for anti-aging containing Phlox subulata extract
CN101433509A (en) Wild chrysanthemum extract and use thereof in cosmetics for resisting age of skin
KR101617730B1 (en) Cosmetic composition with the extract of ginseng berry and grape seed and cosmetics using the same
KR100954984B1 (en) Anti-inflammatory cosmetic compositions containing of herb medicines
FR3106755A1 (en) MURRAYA KOENIGII EXTRACT AND ITS USE IN COSMETICS
KR101052092B1 (en) Cosmetic composition containing herbal extracts and extraction method thereof
KR100438008B1 (en) A COSMETIC COMPOSITION CONTAINING AN EXTRACT OF Cinnamomum camphora
KR102628074B1 (en) skin external application composition for anti-aging containing Luzula capitate extract
KR102137952B1 (en) Cosmetic composition with skin soothing effect
TWI827537B (en) Preparing method of cosmetic composition using skin cosmetic solution

Legal Events

Date Code Title Description
E902 Notification of reason for refusal
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant